Alimera Sciences to Hold Conference Call to Discuss Complete Response Letter Regarding New Drug Application for ILUVIEN(R)

ATLANTA, Dec. 26, 2010 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq:ALIM) (“Alimera”), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will host a conference call at 8:30 a.m. ET on Monday, December 27, 2010 to discuss the Complete Response Letter from the U.S. Food [...] http://bit.ly/dWg4cA